Zhejiang Starry Pharmaceutical Co.,Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 565.91 million compared to CNY 517.3 million a year ago. Revenue was CNY 565.91 million compared to CNY 517.3 million a year ago.

Net income was CNY 9.57 million compared to CNY 80.24 million a year ago. Basic earnings per share from continuing operations was CNY 0.03 compared to CNY 0.24 a year ago. Diluted earnings per share from continuing operations was CNY 0.03 compared to CNY 0.24 a year ago.